• Doctor Radio Feature Interview with Dr. Feldman and Ted Harada

Doctor Radio host, NYU’s Dr. Nieca Goldberg, interviews NSI-566/ALS principal investigator Dr. Eva Feldman and Phase I patient Ted Harada in this expansive one-hour segment on ALS that brought calls from present and past ALS caregivers from around the country. The feature includes firsthand insights on Neuralstem’s completed and upcoming ALS trials. Notably Dr. Feldman said that, while the trial is just entering Phase II, that the team believes the results are extremely promising, and pointed out the heretofore dearth of ALS treatments for this chronic, progressive, neurodegenerative disease since Lou Gehrig was diagnosed in the 1930’s. Ted shared poignant and heartfelt “new lease on life” memories after his initial NSI-566 treatment - and a call to action as well as support for the ALS community from his spot on Capitol Hill, where he was meeting with senators and representatives on National ALS Advocacy Day.

Podcast on demand available to SiriusXM Subscribers: Doctor Radio, Women's Health, 5/9/13 10:00-11:00 a.m. ET
http://www.siriusxm.com/ondemand

5/12 and 5/13 Rebroadcast: Women's Health: Sun, 5/12, 2:00 a.m. ET (Sat., 5/11, 11:00 p.m. PT) and Mon, 5/13, 4:00 a.m. ET
http://www.siriusxm.com/freetrial